Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Gastrointest Surg9 May 2025

New risk score predicts mortality after major liver resection

A newly developed preoperative risk score accurately predicts 90-day mortality in patients undergoing major liver resection, identifying five key factors: age ≥ 65 years, type 2 diabetes, primary liver cancer diagnosis, an American Society of Anesthesiologists score of ≥ 3, and extended hemihepatectomy. The score…

Surg Laparosc Endosc Percutan Tech9 May 2025

Certain patient factors suggest early abandonment in bile duct procedures

A study analyzing 952 laparoscopic common bile duct explorations found an impressive success rate of 89.2%. However, factors like older age, higher American Society of Anesthesiologists (ASA) scores, and the presence of larger or previously identified stones were linked to undesirable outcomes. Surgeons developing their…

Gastrointest Endosc6 May 2025

Interventional EUS improves biliary drainage success in patients

In a retrospective multicenter study of 432 patients with surgically altered anatomy, endoscopic biliary drainage (BD) achieved technical and clinical success rates of 80.3% and 79.9%, respectively. Adverse events were more common in those with Billroth-II reconstruction (14.4%). Notably, the last two years showed increased…

J Gastroenterol4 May 2025

Novel plasma proteins identified as biomarkers for pancreatic cancer

The research highlights keratin 5 (KRT5) and versican (VCAN) as effective biomarkers for early detection and clinical monitoring of pancreatic ductal adenocarcinoma (PDAC). In a multicenter validation study with over 1,000 plasma samples, a combined diagnostic model featuring KRT5, VCAN, and the existing CA 19-9…

World J Surg Oncol4 May 2025

A novel MRI-based model predicts perineural invasion in cholangiocarcinoma

An innovative MRI-based fusion model effectively predicts perineural invasion (PNI) status in intrahepatic cholangiocarcinoma (ICC) patients. The model, incorporating deep learning, radiomics, and clinical features, was developed from a study involving 192 patients. In the training phase, it achieved an AUC of 0.905 and 82.3%…

Ann Surg Oncol3 May 2025

Tumor volume and reduction predict colorectal liver metastases outcomes

Evaluation of total metastases volume (TMV) and relative volume reduction (RVR) reveals their superior predictive ability over established clinical risk scores (CRS) for colorectal liver metastases post-neoadjuvant chemotherapy. Patients with TMV below 29.5 ml before and 7.5 ml after therapy had significantly longer progression-free survival…

Ann Surg Oncol2 May 2025

Indeterminate bile duct cytology carries significant malignancy risks

A systematic review revealed that among 8,458 bile duct samples with indeterminate cytology, the overall risk of malignancy was 60.1%. Specifically, atypical cytology had a malignancy risk of 50.4%, while suspicious cytology exhibited a higher risk at 80.2%. Furthermore, suspicious cytology significantly correlated with a…

Eur J Med Res2 May 2025

Laparoscopic approach reduces postoperative fluid collections and recovery time.

Ultrasonography proved vital in assessing postoperative fluid collections after pancreaticoduodenectomy. A study of 309 patients revealed that those undergoing laparoscopic pancreaticoduodenectomy (LPD) experienced significantly fewer fluid collections (39.2% vs. 59.3%) and shorter hospital stays (16 vs. 21 days). Additionally, LPD patients had reduced fever duration,…

HPB & Spleen2 May 2025

Proton beam therapy effectively manages hepatocellular carcinoma

Through a comprehensive review, researchers highlight the efficacy of proton beam therapy (PBT) in managing hepatocellular carcinoma (HCC), particularly for patients with portal vein tumor thrombosis (PVTT). PBT demonstrates promising tumor local control and overall survival rates while offering a safer alternative to traditional photon…